Form 4: Prothena Corp Public Ltd Co: Officer Acquires 85,000 Stock Options

Sentiment:

SEC Form 4


Brandon S. Smith, Chief Operating Officer of Prothena Corp Public Ltd Co, reports the acquisition of 85,000 stock options.

Summary

  • On February 27, 2024, Brandon S. Smith, the Chief Operating Officer of Prothena Corp Public Ltd Co, acquired 85,000 stock options with an exercise price of $30.30.
  • These options vest over time, with 25% vesting on February 27, 2025, and the remainder vesting monthly over the following 48 months, contingent upon continued employment.
  • Following this transaction, Smith directly owns 85,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to an executive, which is neither particularly positive nor negative on its own.

Positives

  • The acquisition of stock options by a key executive can be seen as a positive sign, aligning their interests with those of the shareholders.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company executives.

Stakeholder Impact

  • The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing performance that benefits the company's value.

Key Dates

DateDescription
02/27/2024Date of transaction: Brandon S. Smith acquired 85,000 stock options.
02/27/202525% of the acquired stock options vest.
02/27/2034Expiration date of the stock options.
02/29/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.